Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report
Open Access
- 29 April 2025
- journal article
- case report
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 1-7
Abstract
Background: DEK::AFF2 fusion squamous cell carcinoma (SCC) is a rare and aggressive subtype of non-keratinizing SCC. Previously reported cases have predominantly involved the sinonasal tract, middle ear, and skull base. To date, only 62 cases have been described, with rare exceptions including a primary lung tumor and a recurrent tumor in the trachea. Methods: We describe the first documented case of primary laryngeal SCC harboring a DEK::AFF2 fusion in a 64-year-old female who presented with progressive hoarseness and airway obstruction. Clinical, radiologic, histopathologic, immunohistochemical, and molecular analyses were performed to characterize the tumor. Results: Imaging and laryngoscopic evaluation revealed a transglottic mass. Histopathology demonstrated non-keratinizing SCC composed of monotonous tumor cells with an infiltrative growth pattern. Immunohistochemistry showed diffuse p40 positivity and moderate to strong nuclear AFF2 expression. The DEK::AFF2 fusion was confirmed by fluorescence in situ hybridization and reverse transcription polymerase chain reaction. The patient underwent total laryngectomy followed by adjuvant chemoradiotherapy and remains disease-free at 12 months of follow-up. Conclusions: This case expands the known anatomical distribution of DEK::AFF2 fusion SCC to include the larynx, suggesting that this rare entity may arise throughout the respiratory tract epithelium. Recognition of this fusion is important in the differential diagnosis of non-keratinizing SCCs across the respiratory tract.Keywords
Funding Information
- National Yang Ming Chiao Tung University
This publication has 21 references indexed in Scilit:
- Recurrent DEK::AFF2 fusion squamous cell carcinoma: prompts for diagnosis of this emerging distinct entityPathology, 2024
- DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging EntityHead and Neck Pathology, 2024
- DEK::AFF2 Carcinoma of the Sinonasal Tract and Skull BaseSurgical Pathology Clinics, 2024
- Diffuse p16 Expression is Against the Diagnosis of DEK::AFF2 CarcinomaIndian Journal of Otolaryngology and Head & Neck Surgery, 2024
- Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entitiesVirchows Archiv, 2024
- Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomasVirchows Archiv, 2023
- The First Report of Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma on Fine-Needle AspirationHead and Neck Pathology, 2023
- Sinonasal DEK-rearranged Papillary Non-keratinizing Squamous Cell Carcinoma: Expanding the Emerging EntityIndian Journal of Otolaryngology and Head & Neck Surgery, 2023
- Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, DEK::AFF2 Fusion, and MAML2 RearrangementHead and Neck Pathology, 2023
- First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case ReportJournal of Thoracic Oncology, 2022